Say hello to your long-term commercial partner

By partnering with you, we bring technical ability and practical agility to unlock the power of your scientific data. From the rarest conditions to more common diseases we improve lives, one patient at a time.

We will be exhibiting at the ISPOR conference 6^th - 8^th May in Atlanta, Georgia, USA. Find out who will be there and what we can offer.

Meet us at ISPOR

Key services

We are committed to launching products that make a difference in people’s lives. We work across a product’s lifecycle, supporting biotech, pharmaceutical, and medical technology companies across the globe.

Outcomes Research

Our team provide unequalled accuracy and quality whilst delivering all aspects of systematic reviews, meta-analyses and patient-level data analyses.

Economic Modelling

We develop a range of robust health economic models that meet the commercial needs of our clients from simple Markov models to complex discrete event simulations.

Health Technology Assessment

We have extensive experience delivering successful HTA submissions in the UK and across the globe.

Value Communication

At FIECON, we understand the value of clear and concise writing, underpinned by robust evidence. We effectively communicate the value of your products in a clear, logical and impactful manner; from global value dossiers to external scientific publications.

Pricing & Reimbursement

We partner with our clients to develop strategies for global pricing and reimbursement, harnessing our extensive KOL and payer network.

FIECON exceeds my expectations by genuinely trying to achieve the best outcomes for our company. Their flexibility to adapt to unexpected changes and apply technical rigour, while respecting the commercial focus of the company is unparalleled. We see FIECON as part of our extended team.”

Senior Market Access Manager, Mid-sized Pharma

It was brilliantly smart and very well explained. It seems obvious now but that is what genius is, making complex things appear simple.”

Associate Director, Mid-sized Pharma

FIECON are my go to trusted partner. The team deliver high-quality work to timeline, every time. But more than this, FIECON has worked as part of our team, working towards achieving the best possible outcome by providing high level strategic input and challenge during our discussions.”

Market Access Director, Small Biotech

FIECON’s highly skilled expert team helped us to successfully tackle a number of tough pricing and access challenges. Apart from their flawless technical expertise, we have a reliable thought partner to pressure test new ideas and strategies that have a broader relevance than purely health economic aspects.”

Disease Area Director, Big Pharma

The pricing and market access research was a high quality work project, which included detailed information to define the overall and country strategy while the gap analysis was instrumental in the next steps preparation. ”

Executive Director, Biotech

FIECON’s strategic approach to problem solving is a breath of fresh air. We highly value their HTA knowledge and expertise, and they consistently deliver the best solution for us.”

Value Demonstration & Access Lead, Big Pharma

It is a pleasure to work with FIECON. The team are passionate about what they do and it really shows in their high-quality, creative solutions. Working with FIECON gives your projects the highest chance of success.”

Senior Vice President, Small Biotech

FIECON’s team is highly experienced, commercially focused, responsive and flexible. A particular strength I highlight is that FIECON’s team becomes a true partner with all company functions that they interact with. ”

Executive Director, Biotech

Company updates

Partnership transformation

We stand at the threshold of a new era in evidence synthesis. FIECON has joined forces with Nested Knowledge, Inc., an industry leader in AI-based SaaS platform solutions. Together, we are on a transformative path, leveraging cutting-edge AI technology to revolutionise the Systematic Literature Review (SLR) and meta-analysis process.

Strategic Council expands expertise

FIECON is excited to announce a significant expansion of the expertise available to clients through the newly formed FIECON Strategic Council.

Times/LDC People First Award 2023

On 18th October FIECON CEOs, Mark and Kuntal Fisher won The Times/LDC People First Award.

Get in touch

Get a completely free, no-obligation opportunity to discuss your need and see how we can boost your business.

Brainstorm solutions to key challenges with experienced team
Validate your strategy and value evidence
Learn more about FIECON’s products and key areas of expertise and discuss opportunities for collaboration

Thank you!

We received your details. Someone from our team will contact you soon.

Oops!

Something went wrong while submitting the form.